Presents cost estimates for six preventive interventions previously identified through a literature review & analysis of peer-reviewed, published research in mental health or substance abuse services. A report by Dorfman in 2000 yielded a number of well-designed research studies. Twenty-one of those studies supported six preventive interventions that demonstrated patient benefits (i.e., better outcomes) or lower use & cost of medical care. The six are: prenatal & infancy home visits for high-risk mothers; smoking cessation targeted at pregnant women; targeted short-term mental health therapy; health promotion through self-care education; pre-surgical educational intervention with adults; & brief counseling to reduce alcohol use.

This report has been prepared to summarize the most promising preventive interventions of a behavioral nature intended to impact mental and substance use disorders, or in some cases, medical outcomes. This review focuses on prevention interventions that are primarily delivered by health care systems. Interventions provided in schools, worksites, communities, and criminal justice systems were excluded, as were population-based interventions.

Managed care has produced dramatic changes in the treatment of mental health and substance abuse problems, known as behavioral health. Managing Managed Care offers an urgently needed assessment of managed care for behavioral health and a framework for purchasing, delivering, and ensuring the quality of behavioral health care. It presents the first objective analysis of the powerful multimillion-dollar accreditation industry and the key accrediting organizations. Managing Managed Care draws evidence-based conclusions about the effectiveness of behavioral health treatments and makes recommendations that address consumer protections, quality improvements, structure and financing, roles of public and private participants, inclusion of special populations, and ethical issues. The volume discusses trends in managed behavioral health care, highlighting the emerging role of the purchaser. The committee explores problems of overlap and fragmentation in the delivery of behavioral health care and discusses the issue of access, a special concern when private systems are restricted and public systems overburdened. Highly applicable to the larger health care system, this volume will be of particular interest to all stakeholders in behavioral healthâ€"federal and state policymakers, public and private purchasers, health care providers and administrators, consumers and consumer advocates, accrediting organizations, and health services researchers.

Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.

The Serial Set contains the House and Senate Documents and the House and Senate Reports. This volume includes Senate Reports from 109th Congress, 2nd Session, 2006.